Thorac Cardiovasc Surg 2017; 65(S 02): S111-S142
DOI: 10.1055/s-0037-1598990
DGPK Oral Presentations
Sunday, February 12, 2017
DGPK: Case Reports
Georg Thieme Verlag KG Stuttgart · New York

Can Cardiac Recovery in Chronic Myocarditis Be Influenced by Training during LVAD Support?

A. Racolta
1   Herz- und Diabeteszentrum NRW, Center for Congenital Heart Defects, Bad Oeynhausen, Germany
,
H. Milting
2   Herz- und Diabeteszentrum NRW, Klessmann-Institut (EHKI), Bad Oeynhausen, Germany
,
V. Lauenroth
3   Herz- und Diabeteszentrum NRW, VAD Koordination, Bad Oeynhausen, Germany
,
J.-P. Horst
1   Herz- und Diabeteszentrum NRW, Center for Congenital Heart Defects, Bad Oeynhausen, Germany
,
E. Klusmeier
1   Herz- und Diabeteszentrum NRW, Center for Congenital Heart Defects, Bad Oeynhausen, Germany
,
R. Vcasna
1   Herz- und Diabeteszentrum NRW, Center for Congenital Heart Defects, Bad Oeynhausen, Germany
,
M. Kantzis
1   Herz- und Diabeteszentrum NRW, Center for Congenital Heart Defects, Bad Oeynhausen, Germany
,
E. Sandica
1   Herz- und Diabeteszentrum NRW, Center for Congenital Heart Defects, Bad Oeynhausen, Germany
,
D. Kececioglu
1   Herz- und Diabeteszentrum NRW, Center for Congenital Heart Defects, Bad Oeynhausen, Germany
,
K.T. Laser
1   Herz- und Diabeteszentrum NRW, Center for Congenital Heart Defects, Bad Oeynhausen, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
02 February 2017 (online)

Objective: A 6-month-old patient with massively impaired left ventricular function: EF 35% (ejection fraction) LVEDD (left ventricular end diastolic diameter) 44 mm–2 SD, VTI (velocity time integral) aortal < Pc 3, Speckle-tracking (ST) longitudinal strain (GLS) 4Ch -6.5%, 2Ch -6.4%). Biopsy revealed histological diagnosis of dilative cardiomyopathy, DD chronical myocarditis. Genetic testing was performed for known cardiomyopathy encoding genes. LVAD-Berlin Heart (BH, left ventricular assist device) implantation 2 days after Admission to hospital because of clinical deterioration. A weaning plan including cardiac muscle training was performed over 14 weeks.

Method: Follow-up using clinical and echocardiographic data (ST, VTI, and 3D-echocardiographic end diastolic [LVEDV], end systolic [LV-ESV], stroke volumes [LV-SV] and EF). Cardiac muscle training for 2 hour/day with reduction of the BH to 55/min for 3 weeks (phase A), extension to 4 hour/day for 2 weeks (phase B) and complete reduction to 55/min for 9 weeks (phase C). In the phase D: pump stop 30 minutes once per week under additional heparin bolus.

Results: The first intended reduction of the pump resulted in LV dilatation and increasing mitral incompetence. The training (phase A) was carried on and revealed an improvement of ST from 8% (GLS 2C) and 10% (GLS 4C) to 13% and respectively 11%. The VTIs were initially between Pc 3–10 and increased to Pc 10. Phase B showed at the beginning an increase of the LVEDV from 55 to 57 mL/m2. At the end of the phase it remained constant with 59 mL/m2 as well as VTI (10.Pc) and EF (36–32%). In phase D during pump stop, we assessed an increase of the VTIs and EF and an adequate increase of SV. ST proved a mild improvement (last test in the attached [Table 1]). Final hemodynamic testing in the cath. laboratory: BH50/min: CI (cardiac index) 4.1 mL/m2/min, CVS (central venous saturation) 60%, LVEDP (left ventricular end diastolic pressure) 8 mm Hg, Off BH 30 minutes: CI 3.6 mL/min/m2, CVS 58%, LVEDP 10 mm Hg. The explantation of the device was successful.

Conclusion: Training of impaired cardiac muscle under LVAD in children with not acute myocarditis may be a possibility to prevent the direct way as bridge to transplant in selected patients. New echocardiographic tools may help assess improvement of function with impact on prognosis.

Table 1

Measurements phase D

Pump on

Pump off 15 min

Pump off 30 min

Heart rate/min

100

113

118

VTI pulmonal (cm)

15

16

16

VTI aortal (cm)

16

20

20

LVEDV (mL/m2)

79

76

LV-SV (mL)

18

15

EF%

44

50

GLS4CH%

−11

−10

−12

GLS2CH%

−10

−10

−15